Posez votre question en utilisant le formulaire ou appelez-nous : +32 2 556 49 60
"*" indicates required fields
Whitepaper ESMO 2023
The ESMO sessions on targeted therapy in metastatic melanoma: were you unable to attend?
Sign up for your whitepaper and get access to:
- Data on patient outcomes and quality of life
- The most important targeted therapies highlights
- Latest news on biomarkers in melanoma
ESMO 2023 white paper application form
Yes, I would like to receive the ESMO white paper on targeted therapy in metastatic melanoma!
‘*’ Displays required fields